Physician profile
Steven Michael Blount
NPI 1386683118
$1,744.86
in general payments reported to CMS, 2019-2025
12 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $71.76 · 2021: $122 · 2022: $299 · 2023: $289 · 2024: $376 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $738.36 | 2021-2024 | Pipeline, Axium Primetm, Rist |
| Medtronic USA, INC. | $240.15 | 2019-2020 | |
| Sirtex Medical INC | $190.04 | 2020-2024 | Sir-Spheres Microspheres |
| Siemens Medical Solutions USA, INC. | $158.90 | 2025 | Microthermx Microwave Ablation System, Intelliblate Microwave Ablation System Console, Artis Icono Biplane |
| Penumbra, INC. | $120.69 | 2021-2022 | |
| Imperative Care, INC | $110.32 | 2024-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| W. L. Gore & Associates, INC. | $41.74 | 2019 | |
| Bard Peripheral Vascular, INC. | $38.03 | 2019 | |
| Boston Scientific Corporation | $36.04 | 2019-2022 | |
| Trisalus Life Sciences, INC. | $34.88 | 2025 | Trinav Infusion System |
| Philips North America LLC | $22.70 | 2025 | Azurion 7 B20 |
| Angiodynamics, INC. | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Blount listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.